This information is for reference purposes only. It was current when produced and may now be outdated. Archive material is no longer maintained, and some links may not work. Persons with disabilities having difficulty accessing this information should contact us at: https://info.ahrq.gov. Let us know the nature of the problem, the Web address of what you want, and your contact information.
Please go to www.ahrq.gov for current information.
Appendix BB. FY 2004-2005 PART Summaries
Program Assessment Rating Tool Evaluations
For the FY 2006 President's budget, the Office of Management and Budget (OMB)
picked several programs at each agency across the Federal government to review.
These performance assessments were developed using the program assessment rating
tool (PART).
The PARTs are a series of questions designed to provide a consistent approach to rating programs across the Federal Government. PARTs are diagnostic tools that rely on professional judgment to assess and evaluate programs across a wide range of issues related to performance.
Data Collection and Dissemination / Patient
Safety / Pharmaceutical Outcomes / Translating
Research Into Practice
Program: Data Collection and Dissemination
Agency: Department of Health and Human Services
Bureau: Agency for Healthcare Research and Quality
| Key Performance Measures |
Year |
Target |
Actual |
Long-term Measure:
Number of months after the date of completion of the
Medical Expenditure Panel Survey data will be available
(New measure) |
1997 |
|
19-27 |
| 2008 |
12 |
|
| |
|
|
| |
|
|
Long-term Measure:
Number of organizations that will use Healthcare Cost and
Utilization Project databases, products or tools to improve
statewide health care quality for their constituencies
(New measure, baseline under development) |
2010 |
5 |
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
|
| |
|
|
| |
|
|
| |
|
|
Rating: Moderately Effective
Program Type: Research and Development.
Last Assessed: 2 years ago.
| Recommended Followup Actions |
Status |
| Propose an increase of $5 million above 2003 Budget to support
AHRQ's efforts to ensure continued collection and availability of natural
health care cost, use, and quality data. |
Completed |
| AHRQ has begun to address management deficiencies by adopting
performance-based contracts that require superior performance toward achieving
established goals. |
Action taken, but not completed |
| Collect performance data on the new measures. |
Action taken, but not completed |
Program Funding Level (in millions of dollars)
2004
Actual |
2005
Estimate |
2006
Estimate |
| 65
|
65 |
63 |
Update on Followup Actions:
AHRQ is currently in the process of developing annual measures that will demonstrate this program's progress towards achieving its long-term goals.
Top of Page
Program: Patient Safety
Agency: Department of Health and Human Services
Bureau: Agency for Healthcare Research and Quality
| Key Performance Measures |
Year |
Target |
Actual |
Long-term Measure:
Number of medical errors identified while decreasing the number of severe errors
occurring |
2005 |
Est Stds |
Est Stds |
| 2010 |
0.9 |
0.9 |
| 2006 |
Monitor |
Monitor |
| |
|
|
Long-term Measure: Percent of hospitals reporting on adverse events as standard practice |
2010 |
5 |
|
| |
|
|
| |
|
|
| |
|
|
Annual Measure:
Number of hospitals that have successfully deployed hospital practices. |
2003 |
PSI/5 implement |
|
| 2004 |
15 State/Org |
|
| 2005 |
+15 State/Org |
|
| 2006 |
+15 State/Org |
+15 State/Org |
Rating: Adequate
Program Type: Research and Development Competitive Grant
Last Assessed: 1 year ago.
| Recommended Followup Actions |
Status |
| Continue to urge AHRQ to request reports from grantees on
research findings and the potential to replicate good models across the
country. |
Action taken, but not completed |
| Monitor AHRQ's progress toward developing baselines for newly
developed long-term and annual performance goals. |
Action taken, but not completed |
Program Funding Level (in millions of dollars)
2004
Actual |
2005
Estimate |
2006
Estimate |
| 80 |
84 |
84 |
Update on Followup Actions:
AHRQ is currently in the process of developing additional annual measures
that will demonstrate this program's progress towards achieving its long-term
goals.
Top of Page
Program: Pharmaceutical Outcomes
Agency: Department of Health and Human Services
Bureau: Agency for Healthcare Research and Quality
- Purpose: 80%
- Planning: 70%
- Management: 80%
- Results/Accountability: 67%
| Key Performance Measures |
Year |
Target |
Actual |
Long-term Measure:
Reduce congestive heart failure hospital readmission rates during the first six
months. |
2000 |
Baseline |
38% |
| 2014 |
20% |
|
| 2006 |
36% |
|
| 2010 |
28% |
|
Long-term Measure:
Reduce hospitalizations for upper DI bleeding in those ages 65-85. |
2000 |
Baseline |
55/10,000 |
| 2014 |
45/10,000 |
|
| 2006 |
53/10,000 |
|
| 2010 |
49/10,000 |
|
Long-term Measure:
Decrease prescriptions of antibiotics for children between ages 1 and 14. |
2001 |
Baseline |
.56/year |
| 2014 |
.42/year |
|
| 2006 |
.50/year |
|
| 2010 |
.46/year |
|
Rating: Moderately Effective
Program Type: Research and Development, Block/Formula Grant
Program Summary:
The Pharmaceutical outcomes Portfolio (POP), through their Centers for Education and Research on Therapeutics (CERTS), conducts state-of-the-art clinical and laboratory research to inform clinical practitioners and policy makers about both the uses and risks of new drugs and drug combinations, biological products, and devices as well as of mechanisms to improve their safe and effective use.
The assessment found that:
- The program possesses a clear and unique purpose and is well designed
to conduct and evaluate research on new drugs and health products and provide
those findings to clinicians and policy makers so that these products best
serve the public's health.
- The program has developed new long-term outcome goals that are directly
linked to performance measures that support the long-term goals for the
program.
- The agency regularly collects timely and credible performance information
by requiring every awardee to provide progress reports to Program Officers
on a regular basis.
- The program has not demonstrated how funding, policy or legislative decisions
impact its expected performance nor does it explain why a particular
funding level or performance result is the most appropriate.
- AHRQ does not conduct periodic comparisons of the potential benefits
of its pharmaceutical outcomes research with those of NIH that have similar
goals.
In response to these findings, the Administration will:
- Tie together the Pharmaceutical Outcomes performance with the budgetary resources it has requested.
- Update baselines and targets for annual performance measures that continue to be developed and realized.
Program Funding Level (in millions of dollars)
2004
Actual |
2005
Estimate |
2006
Estimate |
| 13 |
27 |
26 |
Top of Page
Program: Translating Research Into Practice
Agency: Department of Health and Human Services
Bureau: Agency for Healthcare Research and Quality
| Key Performance Measures |
Year |
Target |
Actual |
Long-term Measure:
Rate of hospitalizations for pediatric asthma in persons
under age 18
(Modified existing measure) |
2000 |
38% |
38% |
| 2005 |
|
28% |
| 2010 |
105,613 |
37% |
| 2006 |
|
36% |
Long-term Measure:
Number of immunization- preventable pneumonia hospital
admissions of persons aged 65 and older
(Modified existing measure) |
2000 |
550/100K |
550/100K |
| 2005 |
|
1.8% drop |
| 2010 |
520,441 |
1.8% drop |
| 2006 |
|
1.8% drop |
Long-term Measure:
Number of immunization-preventable influenza hospital
admissions of persons aged 65 and older
(Modified existing measure) |
2000 |
0.56 |
0.56 |
| 2005 |
|
2% drop |
| 2010 |
11,570 |
2% drop |
| 2006 |
|
2% drop |
Rating: Adequate
Program Type: Research and Development.
Last Assessed: 2 years ago
| Recommended Followup Actions |
Status |
| Maintain funding at the 2003 budget level to ensure continued efforts to go beyond collecting data to actually changing provider behavior and thus improving health outcomes.
|
Completed
|
| The program is addressing its management deficiencies and will begin better integrating its planning and budget decisionmaking processes.
|
Action taken, but not completed
|
Program Funding Level (in millions of dollars)
2004
Actual |
2005
Estimate |
2006
Estimate |
| 8 |
6 |
1 |
Top of Page
Return to Congressional Justification: Program Assessment Rating Tool
Return to Exhibits
Proceed to Exhibit CC